Program Year 2026 Civilian Commercialization Readiness Pilot Program (CCRPP)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Civilian Commercialization Readiness Pilot Program (CCRPP) for 2026, solicited under 80NSSC26R0013, is a competitive federal initiative designed to accelerate the commercialization of technologies developed through SBIR and STTR Phase II programs. Eligible small businesses may apply for funding that combines private sector investment with matching NASA funds ranging from $500,000 to $2.5 million per award, with a maximum total award value of $5 million. This program is not intended for incremental development but rather to propel high-potential, heavyweight technologies toward rapid transition into both NASA missions and commercial markets, as mandated under 15 U.S.C. 638(uu). Applications must be submitted electronically via the ProSAMS portal by the deadline of August 19, 2026, and are limited to small business concerns as defined by the SBA, with a full small business set-aside in place under FAR 19.5. The program requires strict adherence to U.S. manufacturing and ownership standards, with prohibitions on funding activities involving China or designated foreign entities, and mandates disclosures of any foreign affiliations or investments. The evaluation process prioritizes scientific and technical merit, the qualifications and facilities of the proposing team, the effectiveness of the proposed work plan, and most critically, the commercial potential and feasibility of the technology, including its market strategy, competitive landscape, intellectual property safeguards, and past commercialization success. Proposals must include a technical application of no more than 30 pages, a detailed budget, a letter of commitment from private investors, commercialization metrics, and multiple certification and disclosure forms, particularly regarding foreign relationships and vendor sourcing. Contracts are awarded on a firm fixed-price basis with a standard 24-month performance period, extendable to 30 months, and require compliance with extensive NASA-specific clauses covering intellectual property ownership, IT security, sensitive data handling, reporting, and whistleblower protections. Invoicing is conducted exclusively through the Treasury’s Invoice Processing Platform, and all work must occur within the United States using American-made equipment and materials. Failure to meet disclosure obligations, use of prohibited foreign entities, or noncompliance with reporting, security, or personnel requirements may result in disqualification or contract termination.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Timeline
Response Deadline
Organization & Contact Information
Full Description
The Civilian Commercialization Readiness Pilot Program (CCRPP) was reauthorized under the Small Business Innovation and Economic Security Act in 2026. The CCRPP accelerates the transition of SBIR and STTR funded technologies to commercialization through a combination of additional SBIR/STTR program investment and NASA or non-NASA entity sponsor investment.
Eligible small business firms may submit a CCRPP application for the 2026 award cycle in response to this call. If selected for award, NASA will match the investments with SBIR/STTR program funds between $500,000 and $2.5 million for each CCRPP award. Applications must be submitted via ProSAMS.
The goal of Civilian Commercialization Readiness Pilot Program (CCRPP) is commercialization impact. CCRPP awards are not designed for the incremental changes of earlier phases of development. Rather, these heavyweight technologies are running an accelerated path into transitioning to NASA missions and applications as well as commercial markets. Title 15 of the United States Code 638, section uu, [15 U.S.C. 638 (uu)], indicates CCRPP funds awarded to an eligible entity may only be used for research and development activities that build on eligible entity's Phase II program and ensure the research funded under such Phase II is rapidly progressing towards commercialization.
